サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439580

経橈骨動脈アクセス製品 - 世界市場の考察、競合情勢、市場予測（2030年）

Transradial Access Products - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
経橈骨動脈アクセス製品 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の経橈骨動脈アクセス製品の市場規模は、2023年に19億7,864万米ドル、2030年までに30億3,586万米ドルに達し、2024年～2030年の予測期間にCAGRで7.48％の成長が見込まれます。経橈骨動脈アクセス製品の需要は主に、心血管疾患の有病率の増加、肥満、糖尿病などの生活習慣病の増加、化学療法件数の増加、ロボット支援カテーテルシステムの開発の増加、高齢者や高リスク患者における橈骨動脈アクセスデバイスの使用の増加、技術の進歩などによって促進されており、これらが2024年～2030年の予測期間における経橈骨動脈アクセス製品市場全体の成長に寄与しています。

経橈骨動脈アクセス製品の市場力学

経橈骨動脈アクセス製品市場はさまざまな要因によって製品需要が伸びており、その主な要因の1つは、冠動脈性心疾患、末梢動脈疾患、脳卒中などの心血管疾患の有病率の増加です。例えば、American Heart Association（AHA）（2023）によると、2020年に世界で約2億4,410万人が虚血性心疾患（IHD）を患っていると報告されています。

British Heart Foundation（BHA）（2023）は、世界で14人に1人が心臓病や循環器疾患を患っていると述べています。同じ資料によると、ライフスタイルの変化、老年人口の増加などにより、2022年に世界で約5億5,000万人が心臓および循環器の疾患を抱えて生活しています。

このように、心血管疾患の有病率の増加は経橈骨動脈アクセスデバイスの需要を増加させます。これらのデバイスは、外科手術中にカテーテル治療を行うことで、末梢動脈疾患や冠動脈疾患などの動脈疾患の治療を支援します。

これとは別に、化学療法患者における経橈骨動脈アクセス製品の使用の増加も市場成長を促進すると予測されています。WHO（2023）によると、2020年に世界で約1,810万人のがん患者が報告され、そのうち男性で930万人、女性で約880万人の患者が確認されています。化学療法中の経橈骨動脈アクセスは、超選択的カテーテル治療による化学療法の標的化デリバリーが可能であり、全身毒性を軽減できるなどのさまざまな利点を示しています。また、経皮的肝灌流で化学療法を飽和させる場合、橈骨動脈から化学療法を施行することは可能であり、大腿動脈から化学療法を施行する場合の罹患率やリスクを軽減することができます。したがって、がん患者の増加により化学療法の実施件数が増加し、経橈骨動脈アクセス製品に対する需要が増加します。

さらに、経橈骨動脈アクセス製品の発売や承認が増加していることも、予測期間中の市場成長にとっての好材料とる可能性が高いです。例えば、Terumo Corporationは2021年、血管選択性とナビゲーションを提供する親水性コーティング血管造影カテーテル「RADIFOCUS（TM）Glidecath（TM）R.A.V.I. MG1/MG2」を発売しました。

したがって、2024年～2030年の予測期間に上記の要因が経橈骨動脈アクセス製品市場の成長に寄与します。

しかし、経橈骨動脈アクセス製品に関連するリスクなどが経橈骨動脈アクセス製品市場の成長を抑制する可能性があります。

経橈骨動脈アクセス製品市場は、COVID-19の蔓延を抑制するために必要な措置としてロックダウン規制が実施されたため、一時的に後退した時期がありました。経橈骨動脈アクセス製品の需要は、手術に向けて病院や診療所に入院する患者の減少によって妨げられました。しかし、さまざまな活動が再開され、世界のさまざまな地域でワクチンが投与されるようになり、経橈骨動脈アクセス製品の需要は、診断や外科手術に向けて病院に入院する患者の回復とともに大幅に増加しました。したがって、前述の要因がパンデミック中に経橈骨動脈アクセス製品の需要を推進し、予測期間も同じように成長すると推定されます。

当レポートでは、世界の経橈骨動脈アクセス製品市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 経橈骨動脈アクセス製品市場レポートのイントロダクション

第2章 経橈骨動脈アクセス製品市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 経橈骨動脈アクセス製品市場の主な要因の分析

  • 経橈骨動脈アクセス製品市場の促進要因
    • 生活習慣病の増加による心血管疾患の有病率の増加
    • 小児患者における橈骨動脈アクセスデバイスの使用の増加
    • 経橈骨動脈アクセス製品の技術の進歩
  • 経橈骨動脈アクセス製品市場の抑制要因と課題
    • バスキュラーアクセスデバイスの設置とメンテナンスに伴う高いコスト
  • 経橈骨動脈アクセス製品市場の機会
    • 橈骨動脈アクセスを使用したインターベンション処置に対する選好の高まり

第5章 経橈骨動脈アクセス製品市場のポーターのファイブフォース分析

第6章 経橈骨動脈アクセス製品市場に対するCOVID-19の影響分析

第7章 経橈骨動脈アクセス製品の市場レイアウト

  • 製品別
    • カテーテル
    • ガイドワイヤー
    • シース
    • その他
  • 用途別
    • 診断・インターベンション
    • 投薬
    • 輸血
  • エンドユーザー別
    • 病院、診療所
    • 外来手術センター
  • 地域別
    • 北米の経橈骨動脈アクセス製品の市場規模（2021年～2030年）
    • 欧州の経橈骨動脈アクセス製品の市場規模（2021年～2030年）
    • アジア太平洋の経橈骨動脈アクセス製品の市場規模（2021年～2030年）
    • その他の地域の経橈骨動脈アクセス製品の市場規模（2021年～2030年）

第8章 経橈骨動脈アクセス製品市場の企業と製品のプロファイル

  • AngioDynamics
  • Terumo Medical Corporation
  • Medtronic
  • SCW Medicath Ltd
  • Tianck Medical Co., Ltd.
  • Edwards Lifesciences Corporation
  • Shanghai Kindly Medical Instruments Co., Ltd.
  • Colibri Heart Valve
  • Merit Medical Systems
  • Nipro Medical Corporation
  • Boston Scientific Corporation
  • Cordis
  • Beijing Demax Medical Technology Co., Ltd.
  • BD.
  • Teleflex Incorporated

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Transradial Access Products Market in Global (2021-2030)
  • Table 4: Transradial Access Products Market in Global by Product (2021-2030)
  • Table 5: Transradial Access Products Market in Global by Application (2021-2030)
  • Table 6: Transradial Access Products Market in Global by End-User (2021-2030)
  • Table 7: Transradial Access Products Market in Global by Geography (2021-2030)
  • Table 8: Transradial Access Products Market in North America (2021-2030)
  • Table 9: Transradial Access Products Market in North America by Country (2021-2030)
  • Table 10: Transradial Access Products Market in the US (2021-2030)
  • Table 11: Transradial Access Products Market in Canada (2021-2030)
  • Table 12: Transradial Access Products Market in Mexico (2021-2030)
  • Table 13: Transradial Access Products Market in Europe (2021-2030)
  • Table 14: Transradial Access Products Market in Europe by Country (2021-2030)
  • Table 15: Transradial Access Products Market in France (2021-2030)
  • Table 16: Transradial Access Products Market in Germany (2021-2030)
  • Table 17: Transradial Access Products Market in the United Kingdom (2021-2030)
  • Table 18: Transradial Access Products Market in Italy (2021-2030)
  • Table 19: Transradial Access Products Market in Spain (2021-2030)
  • Table 20: Transradial Access Products Market in the Rest of Europe (2021-2030)
  • Table 21: Transradial Access Products Market in Asia-Pacific (2021-2030)
  • Table 22: Transradial Access Products Market in Asia-Pacific by Country (2021-2030)
  • Table 23: Transradial Access Products Market in China (2021-2030)
  • Table 24: Transradial Access Products Market in Japan (2021-2030)
  • Table 25: Transradial Access Products Market in India (2021-2030)
  • Table 26: Transradial Access Products Market in Australia (2021-2030)
  • Table 27: Transradial Access Products Market in South Korea (2021-2030)
  • Table 28: Transradial Access Products Market in Rest of Asia-Pacific (2021-2030)
  • Table 29: Transradial Access Products Market in the Rest of the World (2021-2030)
  • Table 30: Transradial Access Products Market in RoW by Region (2021-2030)
  • Table 31: Transradial Access Products Market in the Middle East (2021-2030)
  • Table 32: Transradial Access Products Market in Africa (2021-2030)
  • Table 33: Transradial Access Products Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Transradial Access Products Market in Global (2021-2030)
  • Figure 4: Transradial Access Products Market in Global by Product (2021-2030)
  • Figure 5: Transradial Access Products Market in Global by Application (2021-2030)
  • Figure 6: Transradial Access Products Market in Global by End-User (2021-2030)
  • Figure 7: Transradial Access Products Market in Global by Geography (2021-2030)
  • Figure 8: Transradial Access Products Market in North America (2021-2030)
  • Figure 9: Transradial Access Products Market in North America by Country (2021-2030)
  • Figure 10: Transradial Access Products Market in the US (2021-2030)
  • Figure 11: Transradial Access Products Market in Canada (2021-2030)
  • Figure 12: Transradial Access Products Market in Mexico (2021-2030)
  • Figure 13: Transradial Access Products Market in Europe (2021-2030)
  • Figure 14: Transradial Access Products Market in Europe by Country (2021-2030)
  • Figure 15: Transradial Access Products Market in France (2021-2030)
  • Figure 16: Transradial Access Products Market in Germany (2021-2030)
  • Figure 17: Transradial Access Products Market in the United Kingdom (2021-2030)
  • Figure 18: Transradial Access Products Market in Italy (2021-2030)
  • Figure 19: Transradial Access Products Market in Spain (2021-2030)
  • Figure 20: Transradial Access Products Market in the Rest of Europe (2021-2030)
  • Figure 21: Transradial Access Products Market in Asia-Pacific (2021-2030)
  • Figure 22: Transradial Access Products Market in Asia-Pacific by Country (2021-2030)
  • Figure 23: Transradial Access Products Market in China (2021-2030)
  • Figure 24: Transradial Access Products Market in Japan (2021-2030)
  • Figure 25: Transradial Access Products Market in India (2021-2030)
  • Figure 26: Transradial Access Products Market in Australia (2021-2030)
  • Figure 27: Transradial Access Products Market in South Korea (2021-2030)
  • Figure 28: Transradial Access Products Market in Rest of Asia-Pacific (2021-2030)
  • Figure 29: Transradial Access Products Market in the Rest of the World (2021-2030)
  • Figure 30: Transradial Access Products Market in RoW by Region (2021-2030)
  • Figure 31: Transradial Access Products Market in the Middle East (2021-2030)
  • Figure 32: Transradial Access Products Market in Africa (2021-2030)
  • Figure 33: Transradial Access Products Market in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Marker Opportunities
  • Figure 37: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0409

Transradial Access Products Market By Product (Catheter, Guidewire, Sheath, And Others), By Application (Diagnostic & Interventional, Drug Administration, Blood Transfusion, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of cardiovascular diseases and the growing technological advancements in access products such as drug-coated balloons, nanotechnology, and others

The global transradial access products market was valued at USD 1,978.64 million in 2023, growing at a CAGR of 7.48% during the forecast period from 2024 to 2030 to reach USD 3,035.86 million by 2030. The demand for transradial access products is primarily being boosted by the increasing prevalence of cardiovascular diseases, growing lifestyle diseases such as obesity, diabetes, and others, rising number of chemotherapy procedures, increasing development of robotic-assisted catheter systems, growing use of radial access devices in geriatric as well as high-risk patients, along with technological advancements are thereby contributing to the overall growth of the transradial access products market during the forecast period from 2024-2030.

Transradial Access Products Market Dynamics:

The transradial access products market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of cardiovascular diseases such as coronary heart disease, peripheral artery disease, stroke, etc. For instance, according to the American Heart Association (AHA) (2023), it was reported that in 2020 approximately 244.1 million people were living with ischemic heart disease (IHD), globally.

British Heart Foundation (BHA) (2023) stated that globally, 1 in 14 people are living with a heart or circulatory disease. According to the same source, around 550 million people were living with heart and circulatory diseases worldwide in 2022, owing to changing lifestyles, a rising geriatric population, and others.

Thus, the increasing prevalence of cardiovascular diseases will increase the demand for transradial access devices as these devices assist in the treatment of arterial diseases such as peripheral artery disease and coronary artery disease, among others by providing catheterization procedures during the surgical procedure.

Apart from this, the rise in the usage of transradial access products in chemotherapy patients is also expected to drive market growth. According to the WHO (2023), worldwide around 18.1 million cancer cases were reported in 2020, out of these, 9.3 million cases were found in men and around 8.8 million in women. Transradial access during chemotherapy has shown various advantages as transradial access allows for targeted delivery of chemotherapy by super selective catheterization and reduces systemic toxicity. Also, in the case of chemo saturation with percutaneous hepatic perfusion access via the radial artery is a feasible alternative for the delivery of chemotherapy, which may reduce morbidity and the risks usually associated with femoral access. Thus, the increasing number of cases of cancer will increase the number of chemotherapy procedures, thereby increasing the demand for transradial access products.

Further, the increasing launches and approvals of transradial access products are also likely to bode well for market growth during the forecast period. For example, in 2021, Terumo Corporation launched RADIFOCUS(TM) Glidecath(TM) R.A.V.I. MG1/MG2, a hydrophilically coated, angiographic catheter that provided vessel selectivity and navigation.

Therefore, the above-mentioned factors are contributing to the growth of the transradial access products market during the forecast period from 2024-2030.

However, risks associated with transradial access products, and others may restrict the transradial access products market growth.

The transradial access products market experienced a period of a temporary setback as lockdown restrictions were enforced as a necessary step to curb the spread of COVID-19. The demand for transcatheter mitral valve repair devices was disrupted owing to the decline in the number of patients in hospitals & clinics for surgeries. Moreover, manufacturing and research & development activities were halted owing to the imposition of strict lockdown rules and due to a lack of resources However, with the resumption of various activities and with the administration of vaccines across different regions of the world, the demand for transradial access products devices increased significantly with the resumption of patients in hospitals for diagnosis and surgical procedures. Henceforth, the aforementioned factors propelled the demand for transcatheter mitral valve repair dev transradial access products during the pandemic and are estimated to grow similarly during the forecast period.

Transradial Access Products Market Segment Analysis:

Transradial access products market by Product (Catheter, Guidewire, Sheath, and Others), Application (Diagnostic & Interventional, Drug Administration, Blood Transfusion, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the transradial access products market, the catheter category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications related to the segment.

Transradial access (TRA) via the left radial artery is an alternative to traditional transfemoral access for catheter-based procedures that are becoming increasingly relevant in all types of arterial vascular interventions. A routine procedure that can aid in the diagnosis of heart disease is cardiac catheterization. By placing stents and using balloon angioplasty to clear blocked arteries, catheterization is occasionally used to treat heart disease.

decreased risk of bleeding and access site problems, its safety, and growing technological advancements, compared to other conventional products, coupled with a high prevalence of cancer and heart-related disorders.

Cardiac catheterization helps in the diagnosis of multiple heart diseases, including atherosclerosis, cardiomyopathy, congenital heart disease, heart failure, and heart valve disease. With the growing burden of cardiovascular diseases all over the world, the catheter segment is expected to witness significant growth. According to the CDC in 2022, 4.6% of adults in the United States had coronary heart disease in 2020. Additionally, as per the same source (2021), in the United States, about 1.5 million people experience heart attacks and strokes annually. Coronary heart disease is the most prevalent form of heart disease. Thus, the public is becoming more aware of disease management and the value of diagnostics as a result of this worrying situation. Thus, the increasing prevalence of such diseases will increase the demand for catheter-related transradial access products.

Also, rising approvals and launches related to catheter-related transradial access products are projected to exhibit the fastest growth during the forecast period. For instance, in 2021, Medtronic announced the approval of a CE Mark for its radial artery access portfolio, which includes Rist(TM) Radial Access Selective Catheter and Rist(TM) 079 Radial Access Guide Catheter. The Rist 079 Radial Access Guide Catheter is a specifically designed catheter for accessing neuro vasculature through the radial artery versus accessing through the transfemoral artery. This allowed clinicians to reach distal locations while achieving excellent stability in the system.

Therefore, the advantages and applications offered by catheters are predicted to contribute to the increasing demand for this product type thereby driving the growth of the overall transradial access products market during the forecast period.

North America is expected to dominate the overall Transradial Access Products Market:

Among all the regions, North America is estimated to account for the largest share of the transradial access products market in the year 2023. Owing to the factors such as the increasing prevalence of lifestyle diseases such as diabetes, obesity, and others, rising incidences of cardiovascular diseases such as strokes, and coronary artery diseases, among others, rising burden of geriatric patients, and escalating regulatory approvals among others, will create a positive growth in the North America transradial access products market.

For instance, according to Pan American Health Organization (PAHO) (2021), cardiovascular diseases (CVD) account for 40.8 million disability-adjusted life years (DALYs) each year in the United States.

The CDC (2023) stated that every year, about 805,000 people in the United States have a heart attack, and of these 605,000 are a first heart attack.

Also, Leukemia & Lymphoma Society (2021) stated that in 2021, approximately every 3 minutes, one person in the US is diagnosed with Leukemia, Lymphoma, or myeloma. According to the same source, in 2021, approximately 397,501 people were living with or in remission from leukemia in the United States.

Therefore, in such cases, transradial access products prove to be beneficial for the treatment of large patient pools, hence driving the regional market during the forecast period (2024-2030).

Fair or poor health status affects 2.1% of children in the United States in 2020, and 3.3% of children aged 5 to 11 missed 11 or more days of school in the previous 12 months as a result of an illness or injury, according to CDC updates from February 2022. Additionally, according to the aforementioned source, 20.3% of children in the United States between the ages of 6 and 11 are obese. Given that obesity is one of the major risk factors for several diseases, the prevalence of pediatric illness in the nation is anticipated to rise, which will fuel growth in the market under consideration.

Coupled with the factors mentioned above, the increasing regulatory approvals and launches will also drive the market of transradial access products. For instance, in February 2020, RIST Neurovascular, Inc. announced US Food and Drug Administration (FDA) clearance for the RIST Cath Radial Access Long Sheath(TM) (RIST Cath) for the treatment of peripheral, coronary, and neurovascular systems. RIST Cath was the first device designed specifically for accessing the neuro vasculature through the radial artery in the wrist, enabling neurovascular procedures to be performed transradially. Thus, such strategic steps help to increase the demand for transradial access products, thereby driving the North America transradial access products market forward during the forecast period.

Transradial Access Products Market Key Players:

Some of the key market players operating in the transradial access products market include AngioDynamics, Terumo Medical Corporation, Medtronic, SCW Medicath Ltd, Tianck Medical Co., Ltd., Edwards Lifesciences Corporation, Shanghai Kindly Medical Instruments Co., Ltd., Colibri Heart Valve, Merit Medical Systems, Nipro Medical Corporation, Boston Scientific Corporation, Cordis, Beijing Demax Medical Technology Co., Ltd., BD., Teleflex Incorporated, and others.

Recent Developmental Activities in the Transradial Access Products Market:

In November 2022, Merit Medical announced the launch of the PreludeSync EZ radial compression device, which was designed to provide precise two-handed placement and clear visibility of the access site. The product was developed to optimize bleeding prevention for radial artery procedures.

In May 2019, Cordis announced the US launch of the Radial 360 portfolio, offering a complete range of products to facilitate the transradial approach (TRA) for interventional cardiology procedures. The Cordis Radial 360 portfolio is composed of Rain Sheath Transradial Thin-Walled Introducer, Railway Sheathless Access System, diagnostic catheters, and a vascular compression band. The system offered fewer bleeding complications, faster post-procedure mobility, improved patient comfort, less hospital stay, and thereby reduction of in-hospital costs.

Key Takeaways from the Transradial Access Products Market Report Study

Market size analysis for current transradial access products market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the transradial access products market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global transradial access products market

Various opportunities available for the other competitor in the transradial access products market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current transradial access products market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for transradial access products market growth in the coming future?

Target Audience who can be benefited from this Transradial Access Products Market Report Study

Transradial access products providers

Research organizations and consulting companies

Transradial access products-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in transradial access products

Various End-users who want to know more about the transradial access products market and the latest technological developments in the transradial access products market.

Frequently Asked Questions for the Transradial Access Products Market:

1. What are transradial access products?

Transradial access products are tools that are used for percutaneous coronary intervention and coronary angiography. Transradial access is required for a catheterization procedure performed for the diagnosis and treatment of arterial diseases.

2. What is the market for global transradial access products?

The global transradial access products market was valued at USD 1,978.64 million in 2023, growing at a CAGR of 7.48% during the forecast period from 2024 to 2030 to reach USD 3,035.86 million by 2030.

3. What are the drivers for the global transradial access products market?

The demand for transradial access products is primarily being heightened by the increasing prevalence of cardiovascular diseases, growing lifestyle diseases such as obesity, diabetes, and others, rising number of chemotherapy procedures, increasing technological advancements, rising product launches and approvals, and others are thereby contributing to the overall growth of transradial access products market during the forecast period from 2024-2030.

4. Who are the key players operating in the global transradial access products market?

Some of the key market players operating in the transradial access products market include AngioDynamics, Terumo Medical Corporation, Medtronic, SCW Medicath Ltd, Tianck Medical Co., Ltd., Edwards Lifesciences Corporation, Shanghai Kindly Medical Instruments Co., Ltd., Colibri Heart Valve, Merit Medical Systems, Nipro Medical Corporation, Boston Scientific Corporation, Cordis, Beijing Demax Medical Technology Co., Ltd., BD., Teleflex Incorporated, and others.

5. Which region has the highest share in the Transradial Access Products market?

North America is expected to dominate the overall transradial access products market during the forecast period from 2024-2030.

Factors such as the rising prevalence of lifestyle diseases such as diabetes, obesity, and others increasing incidences of cardiovascular diseases such as strokes, and coronary artery diseases, growing use of radial access devices in pediatric patients, and increasing regulatory approvals, among others will drive the overall growth of North America transradial access products market.

Table of Contents

1.Transradial Access Products Market Report Introduction

2. Transradial Access Products Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Transradial Access Products Market Key Factors Analysis

  • 4.1. Transradial Access Products Market Drivers
    • 4.1.1. Rising prevalence of cardiovascular diseases due to increasing lifestyle disorders
    • 4.1.2. The growing use of radial access devices in pediatric patients
    • 4.1.3. Increasing technological advancements in transradial access products
  • 4.2. Transradial Access Products Market Restraints and Challenges
    • 4.2.1. High costs involved in the placement and maintenance of vascular access devices
  • 4.3. Transradial Access Products Market Opportunities
    • 4.3.1. Increasing preference for interventional procedures using radial artery access

5. Transradial Access Products Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Transradial Access Products Market

7. Transradial Access Products Market Layout

  • 7.1. By Product
    • 7.1.1. Catheter
    • 7.1.2. Guidewire
    • 7.1.3. Sheaths
    • 7.1.4. Others
  • 7.2. By Application
    • 7.2.1. Diagnostics & Interventional
    • 7.2.2. Drug Administration
    • 7.2.3. Blood Transfusion
    • 7.2.4. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals & Clinics
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.1.1. United States Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.1.2. Canada Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Transradial Access Products Market Size in USD million (2021-2030)
    • 7.4.2. Europe Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.2.1. France Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.2.5. Spain Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Transradial Access Products Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.3.1. China Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.3.3. India Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Transradial Access Products Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW) Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.4.1. Middle East Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.4.2. Africa Transradial Access Products Market Size in USD million (2021-2030)
      • 7.4.4.3. South America Transradial Access Products Market Size in USD million (2021-2030)

8. Transradial Access Products Market Company and Product Profiles

  • 8.1. AngioDynamics
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Terumo Medical Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Medtronic
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. SCW Medicath Ltd
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Tianck Medical Co., Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Edwards Lifesciences Corporation
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Shanghai Kindly Medical Instruments Co., Ltd.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Colibri Heart Valve
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Merit Medical Systems
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Nipro Medical Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Boston Scientific Corporation
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Cordis
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Beijing Demax Medical Technology Co., Ltd.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. BD.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Teleflex Incorporated
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us